Ann: Appendix 4C - quarterly, page-9

Yep. Agree.

It shows that the business is in a rapid growth phase and scaling up globally.

I am particular excited about the focus on Animal Health, India, China and of course the US.

With product made readily available in most markets to avoid delays in deliveries supporting its attractiveness.

Just wondering how they will effectively deliver into the Chinese market without too many delays.

It will be interesting to see the value assessment of analysts after this announcement. Tarvold, do you know when we can expect this?

Have a great day everyone.

K